MBAI
Check-Cap Ltd.
NASDAQ: MBAI · HEALTHCARE · DIAGNOSTICS & RESEARCH
$1.47
+1.38% today
Updated 2026-04-30
Market cap
$11.08M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.33
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Debt/equity -0.09x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-46000.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-19.11M | $-17.57M | $-25.15M | $4.14M | $4.14M |
| EPS | — | — | — | — | $-2.33 |
| Free cash flow | $-19.19M | $-17.04M | $-8.00M | $-46000.00 | $-46000.00 |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Check-Cap Ltd. trades at $1.47. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.
Frequently asked questions
What is Check-Cap Ltd.'s stock price?
Check-Cap Ltd. (MBAI) trades at $1.47.
Is Check-Cap Ltd. overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Check-Cap Ltd. (MBAI)?
The analyst target price is $—, representing NaN% downside from the current price of $1.47.
Piotroski F-Score?
2/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-130.10%
Beta0.79
50D MA$1.70
200D MA$1.52
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—